NDC 0548-8352 – Baqsimi

Glucagon 3 mg/1 · Powder · Nasal

Human Prescription Drug

Product NDC0548-8352

Product details

Brand name
Baqsimi
Generic name
Glucagon
Labeler
Amphastar Pharmaceuticals, Inc.
Dosage form
Powder
Route
Nasal
Marketing category
NDA · NDA210134
Marketed since
July 24, 2019
Listing expires
December 31, 2026
Pharmacologic class
Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Baqsimi →

Package NDC codes (1)

Package NDCDescriptionSince
0548-8352-022 TUBE in 1 CARTON (0548-8352-02) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSEFeb 7, 2024

Other Baqsimi products